审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向:消化道肿瘤;水凝胶 经验分享:我会经常在梅斯上看大家的经验,想着我要是有经验了也来给大家反馈一下,互相帮助共渡毕业大关: 2022-6-21号投稿 Initial Checks, 6-23号更新投稿 Initial Checks, 6-24号Initial checks have been completed and Editor assignment is being determined, 6-27号Editor assessment The Editor is assessing your submission for peer review, 6-30号Reviewer invitation and assignment in process Reviewers are being invited and responses are being received, 7-4号邮件告知UnderReview,Reviewers assigned and awaiting reviewer scores Reviewers have been assigned and are completing reviews, 8-1号Reviewer invitation and assignment in process Reviewers are being invited and responses are being received, 8-15号Reviews returned - awaiting Editor assessment The Editor is considering the reviews and recommendations in order to make decision on your submission, 8-19号通知大修, 9-11号R1修回, 10-24号Reviews returned - awaiting Editor assessment The Editor is considering the reviews and recommendations in order to make decision on your submission, 11-06号催稿信, 12-01号通知二次返修, 12-13号R2修回, 12-22号Accept Admin completing pre-production checks.
proof到online要多久,有没有大神回答一下?
82
审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向:肿瘤
经验分享:做个记录,一篇关于罕见转移的临床回顾性研究……
20230306 submitted
0308 Administrative checks complete……
100
审稿速度:1.0
偏重的研究方向:肿瘤;长链非编码RNA
经验分享:3/22投稿状态是initial checks; 3/27看状态又变回submitted,这是被拒了吗?
58
审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向:消化道肿瘤;水凝胶
经验分享:我会经常在梅斯上看大家的经验,想着我要是有经验了也来给大家反馈一下,互相帮助共渡毕业大关:
2022-6-21号投稿 Initial Checks,
6-23号更新投稿 Initial Checks,
6-24号Initial checks have been completed and Editor assignment is being determined,
6-27号Editor assessment The Editor is assessing your submission for peer review,
6-30号Reviewer invitation and assignment in process Reviewers are being invited and responses are being received,
7-4号邮件告知UnderReview,Reviewers assigned and awaiting reviewer scores Reviewers have been assigned and are completing reviews,
8-1号Reviewer invitation and assignment in process Reviewers are being invited and responses are being received,
8-15号Reviews returned - awaiting Editor assessment The Editor is considering the reviews and recommendations in order to make decision on your submission,
8-19号通知大修,
9-11号R1修回,
10-24号Reviews returned - awaiting Editor assessment The Editor is considering the reviews and recommendations in order to make decision on your submission,
11-06号催稿信,
12-01号通知二次返修,
12-13号R2修回,
12-22号Accept Admin completing pre-production checks.
212
请问这个期刊是必须交版面费吗
81
投稿命中率:75.0
偏重的研究方向:肿瘤;长链非编码RNA
经验分享:Received: December 30, 2021;
Revised: June 5, 2022;
Accepted: July 4, 2022
两个审稿人,第一个补了点实验,第二个拒稿。补充实验后再投,没多久就接受了。
没有太多的波折
92
Wos到现在去年的没有收录,怎么回事?
130
6月初投稿,9月外审,两次大修及润色,这周接受,还没收到invoice,不知道多少钱
98
偏重的研究方向:肿瘤
经验分享:三个月了还在邀请审稿人。。纠结要不要撤稿
104
审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向:肺癌
经验分享:一篇综述6月投的,11月返回,2个小修一个拒稿,一周修回,12月见刊
96